Notable 52-Week Highs and Lows 8/8: (MEIP) (CETX) (NVDA) High; (TGTX) (FRSH) Low

August 8, 2016 3:16 PM EDT
Get Alerts MEIP Hot Sheet
Trade MEIP Now!
Join SI Premium – FREE

Get daily under-the-radar research with's Stealth Growth Insider Get your 2-Wk Free Trial here.

52-Week High:
  • MEI Pharma, Inc. (Nasdaq: MEIP) $2.28. Helsinn and MEI Pharma announced that they have entered into an exclusive licensing, development and commercialization agreement for Pracinostat, a Phase III-ready drug candidate for the treatment of acute myeloid leukemia (AML) and other potential indications. The deal provides the complementary resources from both organizations to rapidly advance Pracinostat into Phase III clinical development and expand into additional indications, including high-risk myelodysplastic syndrome (MDS).

  • Cemtrex Inc. (Nasdaq: CETX) $6.59. Cemtrex reported Q3 results. Net sales for the three months ended June 30, 2016 increased by 69% to $24,714,853 from $14,665,748 for the three months ended June 30, 2015. EBITDA for the three months ended June 30, 2016 was $1,965,353 as compared to $1,096,586 for the three months ended June 30, 2015, representing a 79% increase.

  • NVIDIA (Nasdaq: NVDA) $59.14. NVIDIA seeing additional upside amid positive Piper commentary today. For more color, click here.
52-Week Low:
  • TG Therapeutics (Nasdaq: TGTX) $5.41. TG Therapeutics reported Q2 EPS of ($0.33), versus the analyst estimate of ($0.29). Revenue for the quarter came in at $30.1 thousand versus the consensus estimate of $40 thousand.

  • Papa Murphy's (Nasdaq: FRSH) $5.27. Papa Murphy's seeing additional pressure following Q2 results reported last week.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Special Reports

Related Entities

Jefferies & Co

Add Your Comment